154 results

• Lawsuit Alleges Risperdal, Zyprexa Caused Breast Cancer Diagnosis

  July 11, 2025

  Irvin Jackson

  A California woman is fighting to keep her Risperdal and Zyprexa breast cancer lawsuit in state court, saying manufacturers failed to warn patients of the risks.

• Large Doses of Antipsychotics May Increase Tardive Dyskinesia Risks: Study

  February 11, 2025

  Martha Garcia

  A new study links high doses of first-generation antipsychotics, like Thorazine, to an increased risk of patients developing involuntary muscle movements known as tardive dyskinesia.

• Reduced Use of Antipsychotics for Dementia Does Not Improve Outcomes for Nursing Home Residents: Study

  January 15, 2025

  Martha Garcia

  The findings of a new study warn that while giving dementia patients antipsychotics to serve as "chemical restraints" puts them at an increased risk of death, there were very few benefits seen from taking them off of the drugs.

• Antipsychotics Linked to Heart Failure, Stroke, Other Health Risks in Dementia Patients: Study

  May 3, 2024

  Martha Garcia

  A new study finds that giving antipsychotics to dementia patients, a practice known as "chemical restraint" carries a wide range of health risks, including life-threatening conditions like heart attacks, strokes and pneumonia.

• Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders

  December 14, 2022

  Irvin Jackson

  A new case study warns that Risperdal side effects could cause a long-term involuntary movement disorder, known as tardive dyskinesia.

• $70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review

  May 18, 2021

  Irvin Jackson

  The Supreme Court has rejected a request to review a $70 million Risperdal ruling against Johnson & Johnson over male breast growth side effects, meaning the verdict will stand.

• Antipsychotics Boxed Warning Curbed Use As “Chemical Restraint” In Nursing Homes: Study

  April 30, 2020

  Russell Maas

  A new study finds that FDA warnings reduced the use of antipsychotics as chemical restraints on elderly nursing home residents, but in many cases, the facilities may have switched to other drugs which caused different health problems.

• Judge Determines Johnson & Johnson Should Be Required to Pay $6.8M in Punitive Damage For Failing to Warn About Risperdal Risks

  January 20, 2020

  Irvin Jackson

  A Pennsylvania judge upheld a massive Risperdal verdict, but reduced the original punitive damages from $8 billion to $6.8 million.

• Psychotropic Drugs May Cause Weight Gain By Altering Your Genes: Study

  January 17, 2020

  Martha Garcia

  A new study indicates psychotropic drugs cause genetic changes which leads to weight gain.

• Only 1% of Serious Adverse Drug Events Reported To FDA: Report

  December 19, 2019

  Irvin Jackson

  A new study warns that only about 1-in-100 serious adverse drug events are reported to the FDA.